AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 52 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $30,000 | -80.5% | 10,963 | -84.6% | 0.00% | – |
Q4 2018 | $154,000 | -86.7% | 71,149 | -82.0% | 0.00% | – |
Q3 2018 | $1,157,000 | +7.5% | 395,018 | -2.8% | 0.00% | – |
Q2 2018 | $1,076,000 | +120.9% | 406,264 | +1074.2% | 0.00% | – |
Q1 2018 | $487,000 | +289.6% | 34,600 | +224.3% | 0.00% | – |
Q4 2017 | $125,000 | -35.6% | 10,669 | -22.1% | 0.00% | – |
Q3 2017 | $194,000 | – | 13,688 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |